Megma NS 0.9% Infusion
Marketer
Ridhima Biocare
Salt Composition
Sodium Chloride (0.9% w/v)
Overview Megma NS 0.9% Infusion
Normal saline (0.9%) Megma NS Infusion, a sterile isotonic solution, provides short-term fluid resuscitation. Indicated for hypovolemia stemming from dehydration or trauma, it replenishes essential electrolytes and sodium. Administration requires healthcare professional oversight. Contraindicated in patients with known allergies to the infusion. Blood pressure monitoring and periodic blood tests may be necessary during treatment. Potential side effects include injection site irritation, low blood pressure, pyrexia, tremors, and rigors. Report any concerning symptoms to your physician. Pregnant or breastfeeding individuals, and those with renal impairment, should inform their doctor before treatment, as dosage modification might be needed. This infusion is generally safe for patients with hepatic disease.
Uses of Megma NS 0.9% Infusion
Managing acute fluid deficits following injury; Rehydration therapy
Major Benefits of Megma NS 0.9% Infusion:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Megma NS 0.9% Infusion:
- Injection site reactions (pain, swelling, redness)
- Hypotension (low blood pressure)
- Fever
- Tremors
- Chills
How to use Megma NS 0.9% Infusion:
This medication will be administered by your healthcare provider. Self-medication is not advised.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Megma NS 0.9% Infusion may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Megma NS 0.9% Infusion during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on Megma NS 0.9% Infusion use while breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Administering Megma NS 0.9% Infusion may induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should receive 0.9% sodium chloride infusion (Megma NS) with close monitoring. Dosage modifications for Megma NS 0.9% Infusion may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Megma NS 0.9% Infusion in patients with hepatic impairment is likely safe. Available evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
What if you forget to take Megma NS 0.9% Infusion :
Omit a dose of Megma NS 0.9% Infusion? Seek medical advice.
Facts to Know About Megma NS 0.9% Infusion
| Label | Value |
|---|---|
| Chemical Type | Chlorides of Alkali Metals |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
3,018 People bought this recently